Fundraising Fox
/Companies
Sign in

Opticyte

Seattle, US · Founded 2016 · 9 employees on LinkedIn · 1 known investors

Find your way into Opticyte

Each arrow is one introduction. Sign up to fill in the first one.

122 people can intro you to Lori

Ask Paul Jenny to introduce you to Lori Arakaki

You →Paul · together at University of Washington →Lori

Sign up to find every way you can get introduced to Opticyte

  • Your email: who you already know at Opticyte, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Opticyte team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.

BiotechHealthtechMedical Devices

Founders & leadership

Opticyte was founded in 2016 by Lori Arakaki.

LALori Arakaki
Lori ArakakiFounder · Chief Executive OfficerLori Arakaki is the founder of Opticyte and has a background in bioengineering, with research expertise in developing algorithms for measuring component concentrations in biological optical spectra.
RM
Robert MastersonNamed on SEC filing
KS
Kenneth SchenkmanNamed on SEC filing
LA
Lorilee ArakakiNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$72.3K disclosed across 1 of 2 rounds · 2017–2021

▶$72.3KraisedOct 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MastersonExecutive Officer, Director, Promoter
  • Kenneth SchenkmanExecutive Officer, Director, Promoter
  • Lorilee ArakakiExecutive Officer, Director, Promoter
Offering amount
$2.3M
Amount sold
$72.3K
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Triple Ring Technologies

Companies working in the same space as Opticyte.

In the news

GeekWire: UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure - Opticyteopticyte.com · Jan 2021

Frequently asked questions

What does Opticyte do?
Opticyte develops the VitalO₂, a preclinical-stage medical device aimed at hospitals, with an FDA De Novo pathway and Breakthrough Device Designation. The company operates in the medical device sector.
Who founded Opticyte?
Opticyte was founded by Lori Arakaki in 2016.
Who are Opticyte's investors?
Opticyte's investors include Swan Venture Fund.
How much funding has Opticyte raised?
Opticyte has disclosed $72.3K raised across 1 of its 2 known rounds.
Where is Opticyte headquartered?
Opticyte is headquartered in Seattle, US.